Schwarzbaum S, Nissim A, Alkalay I, Ghozi M C, Schindler D G, Bergman Y, Eshhar Z
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Eur J Immunol. 1989 Jun;19(6):1015-23. doi: 10.1002/eji.1830190610.
The generation of anti-IgE monoclonal antibodies has permitted the identification of various serological epitopes on the IgE molecule. The relationship of the sites on IgE recognized by such antibodies to the Fc epsilon receptor (Fc epsilon R) interaction site has been determined using cross-inhibition studies. However, interpretation of this type of experiment is limited by problems of steric hindrance. Thus, to accomplish precise mapping on the IgE molecule of the Fc epsilon R interaction site and the binding sites of various anti-IgE mAb, we employed site-directed mutagenesis of the IgE heavy chain gene. To this end we have constructed and expressed a recombinant murine constant epsilon heavy chain (C epsilon) gene bearing a (4-hydroxy-3-nitrophenyl)acetic acid (NP)-binding VH region. Several site-specific mutants in the C epsilon 3 and C epsilon 4 domains of this recombinant C epsilon gene were prepared and expressed by transfection into the light chain-producing J558L myeloma cell line. The resulting IgE antibodies were tested for binding to mast cells and to various anti-IgE mAb. The mutants produced include a proline to histidine point mutant at amino acid residue 404 in the C epsilon 3 domain, a mutant with a truncated C epsilon 4 domain, a mutant with a 45 amino acid deletion in the carboxy end of C epsilon 3, and a chimeric human C epsilon in which the human C epsilon 3 was replaced by the homologous mouse C epsilon 3 domain. These mutants have permitted the localization, to the C epsilon 3 domain, of the epitopes recognized by the 84.1C and 95.3 anti-IgE mAb. The 84.1C mAb recognizes a site on IgE which is identical or very close to the Fc epsilon R binding site, and 95.3 recognizes a site on IgE which is related, but not identical to the Fc epsilon R binding site. The antigenic determinant recognized by the 51.3 mAb, which is inefficient at blocking the IgE-Fc epsilon R interaction, has been mapped to the C epsilon 4 domain. When tested for binding to the Fc epsilon R on RBL-2H3 cells, the point mutant bound to the Fc epsilon R with twofold reduced affinity, while the C epsilon 3 deletion mutant and the mutant truncated in C epsilon 4 lost all receptor binding activity.(ABSTRACT TRUNCATED AT 400 WORDS)
抗IgE单克隆抗体的产生使得人们能够鉴定出IgE分子上的各种血清学表位。利用交叉抑制研究确定了此类抗体识别的IgE上的位点与Fcε受体(FcεR)相互作用位点之间的关系。然而,这类实验的解释受到空间位阻问题的限制。因此,为了精确绘制FcεR相互作用位点以及各种抗IgE单克隆抗体结合位点在IgE分子上的图谱,我们对IgE重链基因进行了定点诱变。为此,我们构建并表达了一个携带(4-羟基-3-硝基苯基)乙酸(NP)结合性VH区域的重组小鼠恒定ε重链(Cε)基因。通过转染到产生轻链的J558L骨髓瘤细胞系中,制备并表达了该重组Cε基因Cε3和Cε4结构域中的几个位点特异性突变体。对产生的IgE抗体进行了与肥大细胞及各种抗IgE单克隆抗体结合的检测。所产生的突变体包括Cε3结构域中氨基酸残基404处脯氨酸到组氨酸的点突变体、Cε4结构域截短的突变体、Cε3羧基末端缺失45个氨基酸的突变体,以及人Cε3被同源小鼠Cε3结构域取代的嵌合人Cε。这些突变体已将84.1C和95.3抗IgE单克隆抗体识别的表位定位到Cε3结构域。84.1C单克隆抗体识别IgE上一个与FcεR结合位点相同或非常接近的位点,而95.3识别IgE上一个与FcεR结合位点相关但不相同的位点。51.3单克隆抗体识别的抗原决定簇在阻断IgE-FcεR相互作用方面效率不高,已被定位到Cε4结构域。当检测其与RBL-2H3细胞上FcεR的结合时,点突变体与FcεR的结合亲和力降低了两倍,而Cε3缺失突变体和Cε4截短突变体则失去了所有受体结合活性。(摘要截短于400字)